Healthcare -
Biotechnology - NASDAQ - US
$ 26.51
-1.47 %
$ 1.57 B
Market Cap
-18.21
P/E
JANX - REVENUE
Revenue JANX - Janux Therapeutics, Inc.
10.6 M
LAST VALUE
10.88%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR